State Street’s Blonder Tongue Laboratories Inc BDR Stock Holding History

State Street’s Portfolio BDR Stock Details BDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-65,600	Closed	-$42K	–	5004
2022 Q1	$42K	Hold	65,600	–	–	﹤0.01%	4826
2021 Q4	$39K	Hold	65,600	–	–	﹤0.01%	4738
2021 Q3	$75K	Sell	65,600 -70,600	-52%	-$87K	﹤0.01%	4603
2021 Q2	$180K	Buy	+136,200	New	+$167K	﹤0.01%	4240

State Street's BDR Position: Q2 2022 in Review

State Street sold out of Blonder Tongue Laboratories Inc (BDR) in Q2 2022, closing a stake of 65,600 shares — an estimated $42K sold.

State Street first reported a position in BDR in Q2 2021 and held it in 4 quarters. The position peaked at $180K in Q2 2021. 0 funds tracked by Wall St. Rank hold BDR as of Q2 2022.

State Street reported no remaining Blonder Tongue Laboratories Inc position as of Q2 2022 after selling out during the quarter.
State Street sold 65,600 Blonder Tongue Laboratories Inc shares in Q2 2022, an estimated $42K.
State Street first reported a position in Blonder Tongue Laboratories Inc in Q2 2021 and held it in 4 quarters.
State Street's Blonder Tongue Laboratories Inc position peaked at $180K in Q2 2021.
0 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q2 2022.

Based on State Street's 13F filing for Q2 2022, filed 15 Aug 2022.